These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 10465691

  • 21. Energy-dependent accumulation of calcium antagonists in catecholamine storage vesicles.
    Terland O, Flatmark T.
    Biochem Pharmacol; 2000 Jan 15; 59(2):123-9. PubMed ID: 10810446
    [Abstract] [Full Text] [Related]

  • 22. Movement disorders and depression due to flunarizine and cinnarizine.
    Micheli FE, Pardal MM, Giannaula R, Gatto M, Parera I, Paradiso G, Torres M, Pikielny R, Pardal J.
    Mov Disord; 1989 Jan 15; 4(2):139-46. PubMed ID: 2733706
    [Abstract] [Full Text] [Related]

  • 23. 'Wide-spectrum Ca2+ channel antagonists': lipophilicity, inhibition, and recovery of secretion in chromaffin cells.
    Lara B, Gandía L, Torres A, Olivares R, Martínez-Sierra R, García AG, López MG.
    Eur J Pharmacol; 1997 Apr 23; 325(1):109-19. PubMed ID: 9151946
    [Abstract] [Full Text] [Related]

  • 24. Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine.
    Capellà D, Laporte JR, Castel JM, Tristán C, Cos A, Morales-Olivas FJ.
    BMJ; 1988 Sep 17; 297(6650):722-3. PubMed ID: 3147743
    [No Abstract] [Full Text] [Related]

  • 25. The assignment of the Ca2+-ATPase activity of chromaffin granules to the proton translocating ATPase.
    Flatmark T, Grønberg M, Husebye E, Berge SV.
    FEBS Lett; 1985 Mar 11; 182(1):25-30. PubMed ID: 2857662
    [Abstract] [Full Text] [Related]

  • 26. Dotarizine versus flunarizine as calcium antagonists in chromaffin cells.
    Villarroya M, Gandía L, Lara B, Albillos A, López MG, García AG.
    Br J Pharmacol; 1995 Jan 11; 114(2):369-76. PubMed ID: 7881736
    [Abstract] [Full Text] [Related]

  • 27. The effect of polychlorinated biphenyls on the uptake of dopamine and other neurotransmitters into rat brain synaptic vesicles.
    Mariussen E, Morch Andersen J, Fonnum F.
    Toxicol Appl Pharmacol; 1999 Dec 15; 161(3):274-82. PubMed ID: 10620485
    [Abstract] [Full Text] [Related]

  • 28. Presence of a vacuolar H+-pyrophosphatase in promastigotes of Leishmania donovani and its localization to a different compartment from the vacuolar H+-ATPase.
    Rodrigues CO, Scott DA, Docampo R.
    Biochem J; 1999 Jun 15; 340 ( Pt 3)(Pt 3):759-66. PubMed ID: 10359662
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Characterization of a vacuolar proton ATPase in Dictyostelium discoideum.
    Padh H, Lavasa M, Steck TL.
    Biochim Biophys Acta; 1989 Jul 10; 982(2):271-8. PubMed ID: 2526657
    [Abstract] [Full Text] [Related]

  • 31. Potent, extra-channel influence of several calcium-channel modulators on striatal binding of [3H]tyramine.
    Vaccari A, Saba P, Gessa G.
    Neurochem Res; 1993 Nov 10; 18(11):1125-30. PubMed ID: 8255363
    [Abstract] [Full Text] [Related]

  • 32. Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine.
    Chouza C, Scaramelli A, Caamaño JL, De Medina O, Aljanati R, Romero S.
    Lancet; 1986 Jun 07; 1(8493):1303-4. PubMed ID: 2872433
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of neurotransmitter and hormone transport into secretory vesicles by 2-(4-phenylpiperidino)cyclohexanol and 2-bromo-alpha-ergocryptine: both compounds act as uncouplers and dissipate the electrochemical gradient of protons.
    Moriyama Y, Amakatsu K, Yamada H, Park MY, Futai M.
    Arch Biochem Biophys; 1991 Oct 07; 290(1):233-8. PubMed ID: 1680315
    [Abstract] [Full Text] [Related]

  • 34. [Effects of (E)-1-[bis (4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl) piperazine dihydrochloride(flunarizine) on cerebral circulation].
    Kubo K, Karasawa A, Yamada K, Nito M, Shuto K, Nakamizo N.
    Nihon Yakurigaku Zasshi; 1982 May 07; 79(5):383-400. PubMed ID: 7129248
    [Abstract] [Full Text] [Related]

  • 35. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase.
    David P, Nguyen H, Barbier A, Baron R.
    J Bone Miner Res; 1996 Oct 07; 11(10):1498-507. PubMed ID: 8889850
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Vacuolar and plasma membrane proton-adenosinetriphosphatases.
    Nelson N, Harvey WR.
    Physiol Rev; 1999 Apr 07; 79(2):361-85. PubMed ID: 10221984
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.